24 May 2013
Keywords: lilly, pays, bioms, 10m, ms, trial, continues
Article | 01 September 2008
USA-based BioMS Medical Corp says that the independent Drug Safety Monitoring Board for the MAESTRO-01 trial has conducted a scheduled
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
23 May 2013
© 2013 thepharmaletter.com